MustGrow Biologics Corp.
MGROF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $5 | $0 | $0 |
| % Growth | -91.6% | 72,627.3% | -49.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $4 | -$0 | -$0 |
| % Margin | 75.6% | 91.9% | -4,506.9% | -1,484.2% |
| R&D Expenses | $1 | $1 | $0 | $0 |
| G&A Expenses | $3 | $3 | $4 | $2 |
| SG&A Expenses | $4 | $4 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Expenses | $5 | $6 | $6 | $3 |
| Operating Income | -$5 | -$1 | -$6 | -$3 |
| % Margin | -1,284.9% | -17.1% | -87,745% | -23,397.3% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$5 | -$1 | -$6 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$1 | -$6 | -$3 |
| % Margin | -1,228.3% | -14.4% | -85,908.3% | -23,809.2% |
| EPS | -0.095 | -0.014 | -0.11 | -0.07 |
| % Growth | -596.3% | 87.6% | -56.9% | – |
| EPS Diluted | -0.095 | -0.014 | -0.11 | -0.07 |
| Weighted Avg Shares Out | 52 | 50 | 49 | 44 |
| Weighted Avg Shares Out Dil | 52 | 50 | 49 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $5 | $0 | $5 | $3 |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | -151% | -9.9% | -4,692.1% | -2,191.3% |